Madrigal Pharmaceuticals Inc (MDGL) support and resistance · rev $180.1M
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
This page maps Madrigal Pharmaceuticals Inc (MDGL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
MDGL currently screens at market cap $11.56B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MDGL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MDGL quote page for the session range and the stock page for the full model.
Not investment advice.